LGVN — Longeveron Inc.

LGVNLongeveron Inc.

NAS · US · Healthcare · Biotechnology · longeveron.com

0.8385USD+2.26%Mkt Cap: 26.23M USDP/E: —Last update: 2026-05-26

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogenei…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap26.23M USD

Enterprise Value7.45M USD

Revenue (TTM)1.22M USD

Gross Profit803.00K USD

Net Income (TTM)-22.70M USD

Revenue/Share0.0610 USD

Last Price0.8385 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees38

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.47

PEG—

EV/EBITDA-0.34

EV/Revenue6.13

P/S18.74

P/B2.92

EPS (TTM)-1.14

EPS (Forward)-1.53

52W Range

0.475027% of range1.800

52W High1.800 USD

52W Low0.4750 USD

Profitability

Gross Margin66.97%

Oper. Margin-1199.75%

EBITDA Margin0.00%

Profit Margin-1893.58%

ROE-400.07%

ROA-221.26%

Growth

Revenue Growth4.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.64M USD

CapEx (TTM)595.00K USD

FCF Margin-873.08%

FCF Yield-40.48%

Net Debt-15.01M USD

Net Debt/EBITDA0.69

Balance Sheet

Debt/Equity0.15

Current Ratio3.88

Quick Ratio3.64

Book Value/Sh0.2470 USD

Cash/Share0.5060 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateMar 27, 2024

Analyst Consensus

Rating1.7 (Buy)

Target (Mean)7.150 USD

Target Range3.000 USD – 10.45 USD

# Analysts3

Ownership

Shares Out.30.15M

Float26.53M

Insiders9.72%

Institutions9.77%

Short Interest

Short Ratio3.4d

Short % Float9.73%

Short % Out.8.91%

Shares Short2.61M

Short (prev mo.)2.41M

Technical

SMA 500.9386 (-10.7%)

SMA 2000.7530 (+11.4%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)512.12K

Avg Vol (10d)583.81K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—